Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-05 Sale |
2021-04-06 5:54 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
426 | $9.8029 | $4,176 | 121,662 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 4:40 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
422 | $10.15 | $4,283 | 122,088 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-03 7:39 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
415 | $12.23 | $5,076 | 69,664 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 6:36 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
6,548 | $10.23 | $67,016 | 70,079 (Direct) |
View |
| 2020-12-02 Sale |
2020-12-04 4:34 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
92 | $11.65 | $1,072 | 76,627 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-03 7:28 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
97 | $7.81 | $758 | 76,719 (Direct) |
View |
| 2020-10-02 Sale |
2020-10-05 5:25 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
91 | $10.14 | $923 | 76,816 (Direct) |
View |
| 2020-09-02 Sale |
2020-09-03 5:27 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
90 | $9.77 | $879 | 76,907 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:35 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
86 | $10.8 | $929 | 76,997 (Direct) |
View |
| 2020-07-02 Sale |
2020-07-06 8:02 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
660 | $10.67 | $7,040 | 77,083 (Direct) |
View |
| 2020-06-02 Sale |
2020-06-03 5:26 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
89 | $10.66 | $949 | 77,743 (Direct) |
View |
| 2020-05-04 Sale |
2020-05-06 4:55 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
89 | $9.6201 | $856 | 77,832 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-30 Option Award |
2023-12-04 5:55 pm |
N/A 2033-11-30 |
enGene Holdings Inc. | ENGN | BRYCE RICHARD PAUL Chief Medical Officer |
153,000 | $0 | 153,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 6:21 pm |
N/A 2033-02-15 |
Rain Oncology Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-01-07 Option Award |
2022-02-04 4:40 pm |
N/A 2032-01-07 |
Rain Therapeutics Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer |
53,064 | $0 | 53,064 (Direct) |
View |
Ownership |
2021-04-22 7:15 pm |
N/A 2031-04-13 |
Rain Therapeutics Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer |
0 | $0 | 194,462 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 6:22 pm |
N/A 2031-02-16 |
PUMA BIOTECHNOLOGY INC. | PBYI | BRYCE RICHARD PAUL SEE REMARKS |
127,187 | $0 | 196,851 (Direct) |
View |